Logo image
Two cases of aggressive sarcomatoid urothelial carcinoma reveal potential molecular targets
Journal article

Two cases of aggressive sarcomatoid urothelial carcinoma reveal potential molecular targets

Alexandria Hertz, L Lerma, Justin Ahn, Judith Hagedorn, Eric Konnick, Robin Bennett, Petros Grivas, Michael Wagner, Nicholas Reder and Sarah Psutka
European Journal of Medical Case Reports, Vol.5(8), pp.1-8
01/01/2021
DOI: 10.24911/ejmcr/173-1611205898

View Online

Abstract

Background: To detail two cases of sarcomatoid urothelial carcinoma (UC) with rapid progression, disseminated metastases, and early death, detailing the results of somatic tumor profiling using next-generation sequencing (NGS). Case Series: The first case presented is a rare case of UC of the renal pelvis with osteosarcomatous differentiation and venous tumor thrombus in a 65-year-old man found to have a heterozygous germline variant of unknown significance in the neurofibromatosis-1 gene. The second case is a 72-year-old woman with sarcomatoid UC of the bladder. Herein, we discuss the presentation and clinical course, histology, immunohistochemical profiles, and somatic tumor testing results. We then review the literature regarding this rare and aggressive entity, detail options for optimal management, and address the role of molecular profiling in these cases. Conclusion: Sarcomatoid UC is a rare and aggressive entity. NGS may be useful in these cases to guide systemic therapy.
Biopsy Bladder Bladder cancer Blood clots Bone cancer Case reports Cellular biology Genetic counseling Hematuria Histology Kidney cancer Metastasis Mutation Sarcoma Surveillance Tumors Urology Veins & arteries

Details

Metrics

4 Record Views
Logo image